Search

everythinglearnresearchcommunity

for

Search:↓

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

Upadacitinib effectively treats pyoderma gangrenosum.

Sonidegib and vismodegib have different side effects and reporting patterns.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Pro-Ile could be used in cosmetics to improve skin, hair growth, and healing.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Promising cancer treatments were found, but the manufacturer closed.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Targeting the PGD2-DP2 pathway may help treat hair loss.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.